
Contraline Announces 24-Month Safety and Efficacy Results from First-in-Human Trial of ADAM™
CHARLOTTESVILLE, VA, UNITED STATES, April 24, 2025 /EINPresswire.com/ -- Contraline, a clinical-stage male contraception company, today announced that participants in the First-in-Human clinical trial of ADAM™ (“The ADAM Study”) have reached a critical …